Market Scope & Diversity
Many women in countries of the developed world are choosing to not subject themselves to the recommended annual pelvic examinations. Most often this is due to embarrassment, time constraints, lack of insurance, and the desire not to endure the discomfort involved in the current Pap screening methods. In third world countries, access to medical professionals and examination costs are the main factors as to why women do not obtain their routine Pap test.
Letha McGarity/ Online Blogger
SelfPap™ crosses social, economic, cultural and religious barriers and empowers women’s health by putting them in control of when, where and how this important health exam occurs.
With the availability of the SelfPap™ kit, governments, groups and institutions will be able to oﬀer self-screening to women for Cervical Cancer, abnormal cervical cells, HPV, Trichomoniasis, Herpes, Chlamydia, Gonorrhea, Syphilis, and a myriad of other tests. In the developed world this translates to reduced costs and increased access to women’s cervical disease and STD screening. In third world countries these same benefits will apply in addition to the ability to tailor ancillary testing specific to geographic and sociographic prevalence of viral/ bacterial/ fungal disease.